Coronavirus medication can come before vaccine in India, effective in both treatment and prevention

India: A drug of coronavirus is being prepared by CSIR, it is believed that the drug will be ready before the coronavirus vaccine.

This drug named MW has completed a two-stage clinical trial.

Also, the drug regulator has now approved Phase III trials.

On which CSIR senior scientist Dr. Ram Vishwakarma has said that the results of the two phases have been encouraging, which were placed before the drug regulator, after which the third phase has been approved.

Also Read : U.K. to start human trials to drive covid-19 vaccine hunt

The tests will be started soon on about 300 people in the country. Preparations for these tests are being started in selected hospitals like AIIMS, Apollo, etc.

He also stated that the drug would serve as immuno-therapy, which could be given to the patient under treatment and to a healthy person for survival.

In the second phase of testing, it has been seen that the patients are getting better soon after taking it. The virus load in them is rapidly decreasing.

He also said that the Phase III trials will be conducted in select hospitals including AIIMS. Phase II trials were conducted on 42 patients, but Phase III trials would be conducted on 300 people. This drug is already being used in leprosy. CSIR has used it for Coronavirus. Mycobacterium W produces immunity against external infection in the body.

Also Read : Mumbai Police send’s notice to Kangana and Rangoli once again, called for questioning

Cytokines hyperactivity has been observed in Covid-19 which can be harmful. Cytokines are proteins produced by immune cells. Many cells produce these. Their presence keeps the immune system active and controlled in the body.